Abstract

Australia — New Cooperative Research Center for Cancer Therapeutics in Melbourne. Australia — WEHI Collaborates with Genentech to Develop New Cancer Drugs. Australia — Australia Prepares to Vaccinate its Entire Population Against Bird Flu. China — China Revokes Licenses of 160 Drug Firms. China — Three More National Laboratories to be Set up at CAS. China — Covance Expands Operations in China. China — CAS Launches a New Round of Academician Selection with Strict Procedures. China — China Slashes Cost of Overpriced Drugs. China — New Diabetic Drug Manufactured in Shanghai. Japan — Japan Confirms 32nd Mad Cow Case. Japan — New Bird Flu Outbreak Suspected in Japan. Indonesia — Indonesia to Declare Bird Flu a National Disaster. Indonesia — Baxter Collaborates with the Indonesian Government. Indonesia — Indonesia Develops a Bird Flu Vaccine. India — India to Carry Out First Multi-centric Clinical Trial with Stem Cells. India — Lotus Labs and Labindia Team Up to Build a Clinical Research Academy. India — Bangalore to Build Knowledge City. India — Indian Companies to Bid for Merck's Generics Business. India — India and Croatia Pledge One million Euros for Scientific Research. India — India to Lead in Global Stem Cell Market by 2010. India — Biotech Leaders Receive Indian Government Awards. Malaysia — Malaysia Opens a New Laboratory for Hazardous Disease Research. Philippines — Philippines Bans Imports of Live Birds and Poultry from Japan. Singapore — Singapore Keeping up Vigilance Against Infectious Diseases. Singapore — Singapore Health Ministry Considering Legislation on Biomedical Research. Singapore — TNT Appoints Onno Boots as South East Asia's Regional Managing Director. South Korea — South Korea Aims to Become Top 10 Science Nation by 2010. Taiwan — Taiwan Works on Bird Flu Vaccine. Taiwan — Taiwan Introduces World's First DNA chip. Thailand — Bird Flu Strikes in Thailand Again. Thailand — Thai Pharma Industry Against Thai Government's Decision to Produce Generic Drugs.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call